Emerging Markets Earnings: Teva Moves On With Russia, LatAm In Focus
This article was originally published in PharmAsia News
Executive Summary
Teva appears to have eased past a management shakeup and extended its lead in Copaxone with the company ready to expand in emerging markets as the next frontier, led by Russia and Latin America.